A rationale for mTOR inhibitors as chemoprevention agents in Peutz-Jeghers syndrome

Familial Cancer

Volumn 10, Issue 3, 2011, Pages 469-472

  Kuwada, Scott K ^a   Burt, Randall ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoprevention; Clinical trial; Hamartomatous polyps; mTOR; Peutz Jeghers syndrome

Indexed keywords

EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LKB1; RAPAMYCIN;

ADVANCED CANCER; ANGIOMYOLIPOMA; APHTHOUS STOMATITIS; ASTROCYTOMA; BRONCHITIS; CANCER PREVENTION; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; CONFERENCE PAPER; CONVULSION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TARGETING; GENE MUTATION; HUMAN; INTESTINE POLYP; KIDNEY CANCER; KIDNEY CARCINOMA; NONHUMAN; PEUTZ JEGHERS SYNDROME; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STOMATITIS; TREATMENT INDICATION; UPPER RESPIRATORY TRACT INFECTION; VIRAL BRONCHITIS;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; PEUTZ-JEGHERS SYNDROME; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

MAMMALIA;

EID: 80055000509     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9471-9     Document Type: Conference Paper

References (15)

1. Y Matsumoto N Manabe S Tanaka A Fukumoto T Yamaguchi M Shimamoto M Nakao Y Mitsuoka K Chayama 2006 Small-intestinal Peutz-Jeghers polyps resected by endoscopic polypectomy with double-balloon enteroscopy and removal confirmed by ultrasonography Dig Dis Sci 51 2337 2340 17089186 10.1007/s10620-006-9381-0 1:STN:280:DC%2BD2s%2FgtFCisA%3D%3D
2. TC Hsu TC Lee HM Chiu JF Wu TJ Yen TH Hsiao YM Jeng YH Ni 2010 Radical endoscopic polypectomy combined with double-balloon enteroscopy and colonoscopy for Peutz-Jeghers syndrome J Pediatr Gastroenterol Nutr 51 370 372 20601900
3. K Hizawa M Iida T Matsumoto N Kohrogi T Yao M Fujishima 1993 Neoplastic transformation arising in Peutz-Jeghers polyposis Dis Colon Rectum 36 953 957 8404388 10.1007/BF02050632 1:STN:280:DyaK2c%2FgvVersA%3D%3D (Pubitemid 23309034)
4. F Konishi NE Wyse T Muto T Sawada Y Morioka H Sugimura K Yamaguchi 1987 Peutz-Jeghers polyposis associated with carcinoma of the digestive organs. Report of three cases and review of the literature Dis Colon Rectum 30 790 799 3308369 10.1007/BF02554629 1:STN:280:DyaL1c%2Fgtl2gsg%3D%3D (Pubitemid 17168049)
5. WW De Leng AM Westerman MA Weterman FW De Rooij H Dekken Hv AF De Goeij SB Gruber JH Wilson GJ Offerhaus FM Giardiello JJ Keller 2003 Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas Clinical Cancer Res: J Am Assoc Cancer Res 9 3065 3072 (Pubitemid 36993269)
6. N Hearle V Schumacher FH Menko S Olschwang LA Boardman JJ Gille JJ Keller AM Westerman RJ Scott W Lim JD Trimbath FM Giardiello SB Gruber GJ Offerhaus FW de Rooij JH Wilson A Hansmann G Moslein B Royer-Pokora T Vogel RK Phillips AD Spigelman RS Houlston 2006 Frequency and spectrum of cancers in the Peutz-Jeghers syndrome Clin Cancer Res 12 3209 3215 16707622 10.1158/1078-0432.CCR-06-0083 1:CAS:528:DC%2BD28Xks1Chsrk%3D (Pubitemid 43837371)
7. MG van Lier A Wagner EM Mathus-Vliegen EJ Kuipers EW Steyerberg ME van Leerdam 2010 High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations Am J Gastroenterol 105 1258 1264 20051941 10.1038/ajg.2009.725 author reply 1265
8. S Velho C Oliveira A Ferreira AC Ferreira G Suriano S Schwartz Jr. A Duval F Carneiro JC Machado R Hamelin R Seruca 2005 The prevalence of PIK3CA mutations in gastric and colon cancer Eur J Cancer 41 1649 1654 15994075 10.1016/j.ejca.2005.04.022 1:CAS:528:DC%2BD2MXmsVCmu7s%3D (Pubitemid 40981849)
9. A Goel CN Arnold D Niedzwiecki JM Carethers JM Dowell L Wasserman C Compton RJ Mayer MM Bertagnolli CR Boland 2004 Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers Cancer Res 64 3014 3021 15126336 10.1158/0008-5472.CAN-2401-2 1:CAS:528:DC%2BD2cXjs1ehsbo%3D (Pubitemid 38581399)
10. G Hudes M Carducci P Tomczak J Dutcher R Figlin A Kapoor E Staroslawska J Sosman D McDermott I Bodrogi Z Kovacevic V Lesovoy IG Schmidt-Wolf O Barbarash E Gokmen T O'Toole S Lustgarten L Moore RJ Motzer 2007 Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N Engl J Med 356 2271 2281 17538086 10.1056/NEJMoa066838 1:CAS:528:DC%2BD2sXmtVKkurs%3D (Pubitemid 46849157)
11. C Wei CI Amos N Zhang X Wang A Rashid CL Walker RR Behringer ML Frazier 2008 Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling Clin Cancer Res 14 1167 1171 18281551 10.1158/1078-0432.CCR- 07-4007 1:CAS:528:DC%2BD1cXhvF2nsb4%3D (Pubitemid 351302565)
12. C Wei CI Amos N Zhang J Zhu X Wang ML Frazier 2009 Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model Cancer Lett 277 149 154 19147279 10.1016/j.canlet.2008.11.036 1:CAS:528:DC%2BD1MXjslOktbw%3D
13. DB Shackelford DS Vasquez J Corbeil S Wu M Leblanc CL Wu DR Vera RJ Shaw 2009 mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome Proc Natl Acad Sci USA 106 11137 11142 19541609 10.1073/pnas.0900465106 1:CAS:528:DC%2BD1MXptVWgu78%3D
14. J Robinson C Lai A Martin E Nye I Tomlinson A Silver 2009 Oral rapamycin reduces tumour burden and vascularization in Lkb1(±) mice J Pathol 219 35 40 19434632 10.1002/path.2562 1:CAS:528:DC%2BD1MXhtFGgs7%2FK
15. DN Franz J Leonard C Tudor G Chuck M Care G Sethuraman A Dinopoulos G Thomas KR Crone 2006 Rapamycin causes regression of astrocytomas in tuberous sclerosis complex Ann Neurol 59 490 498 16453317 10.1002/ana.20784 1:CAS:528:DC%2BD28XjtV2ltr8%3D (Pubitemid 43358069)